Pfizer Inc
NYSE: PFE
$26.31
+$0.26 (+1.0%)
Closing Price on March 18, 2025
PFE Articles
While most of the 30 stocks on the Dow Jones Industrial closed in the red yesterday, Kraft Foods Inc. (NASDAQ: KFT) and Pfizer (NYSE: PFE) bucked that trend. Kraft climbed 0.71%, according to...
Published:
Drugmaker Eli Lilly & Co. (NYSE: LLY) announced this morning that the company’s solanezumab treatment for Alzheimer’s disease failed to meet both the cognitive and functional endpoints in...
Published:
Elan Corporation, plc (NYSE: ELN) may be surging on news that it is going to spin off its drug research unit, but now there is something else to consider. Elan could be getting closer and closer...
Published:
Last Updated:
Drug maker Pfizer Inc. (NYSE: PFE) has filed a Form S-1 with the SEC for an initial public offering of the company’s animal health unit into a company to be called Zoetis Inc. Pfizer expects to...
Published:
Drug maker Pfizer Inc. (NYSE: PFE) today announced that it has reached settlements with the US Justice Department and the Securities and Exchange Commission related to improper payments (aka, bribes)...
Published:
Chesapeake Energy Corp. (NYSE: CHK) sells assets to improve earnings. (Reuters) Standard Chartered may lose its New York banking license over allegations it hid $250 billion in transactions tied to...
Published:
Johnson & Johnson Inc. (NYSE: JNJ) and Pfizer Inc. (NYSE: PFE) both announced they are stopping development of a drug to treat patients with mild to moderate Alzheimer’s after the drug failed...
Published:
Last Updated:
The three major US stock indexes opened mixed this morning following the unemployment report from the Eurozone, which showed that the 11.2% rate had remained unchanged. The Eurozone consumer price...
Published:
Last Updated:
U.S. stocks are set to open higher on the final day of July. All three indexes are expected to post mild gains for the month. Futures on the Dow Jones Industrial Average are up about 0.2%. S&P...
Published:
Pfizer Inc. (NYSE: PFE) reported second-quarter adjusted earnings per share (EPS) of $0.62 and $15.06 billion in revenue this morning. Adjusted EPS was up from $0.59 in the same period a year ago,...
Published:
Last week was a jam-packed week of earnings reports and this week has many key reports. We have provided earnings previews for 11 companies we expect to follow this week. Estimates are from...
Published:
Last Updated:
The week ahead is going to be a busy week. There are many traditional events to watch, but by now the market participants and investors have learned that they have to pay close attention to many...
Published:
Last Updated:
Usually, shares of drug makers soar following the announcement that the Foood and Drug Administration approved a drug. Amarin Corp. (NASDAQ: AMRN) announced approval by the FDA for Vascepta to...
Published:
A new treatment for Alzheimer’s disease from Pfizer Inc. (NYSE: PFE) and partner Elan Corp. plc (NYSE: ELN) has failed a late-stage trial in patients with mild-to-moderate cases of the disease and...
Published:
Carlyle (NASDAQ: CG) may buy a unit of United Technologies (NYSE: UTX). (Reuters) More factories move to the United States as China’s manufacturing costs rise. (Reuters) The CEOs of Apple (NASDAQ:...
Published:
Our expert who first called NVIDIA in 2009 is predicting 2025 will see a historic AI breakthrough.
You can follow him investing $500,000 of his own money on our top AI stocks for free.